GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza, Wegovy started as a way to treat diabetes but have since become popular for weight loss.
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
The analysis of medical image data can be improved by artificial intelligence (AI) algorithms, latest research has claimed. A new study presented at the international competition AutoPET revealed that ...
Eating pasta and pizza in Italy is better for your blood sugar levels than consuming them in America, a health reporter has demonstrated. Emily Joshu Sterne has discovered that her blood sugar levels ...
Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded. In a Citizen Petition posted on ...
Eli Lilly has asked to intervene in litigation between a compounding pharmacy trade group and the FDA over the agency’s decision to remove Lilly’s blockbuster … ...
Novo Nordisk is continuing its citizen petition crusade at the FDA, this time aiming to stop the compounding of Victoza, its blockbuster GLP-1.
To hear Novo tell it, the outsourcing group OFA shouldn’t be allowed to place liraglutide on its compounding list given that FDA-approved generics to Victoza are available. Further, the OFA has ...